KemPharm appoints COO, CFO
This article was originally published in Scrip
Executive Summary
North Liberty, Iowa-based KemPharm, a clinical-stage biopharmaceutical company, has appointed Gordon Johnson chief operating officer and chief financial officer. Prior to joining the company, which develops therapies to treat pain, Mr Johnson held a number of financial advisory, corporate finance and sales positions at Piper Jaffray & Co, WR Hambrecht, Credit Suisse First Boston, Kidder, Peabody & Co, and Deutsche Bank.